Home > Insider Trading > Filing (0001179110-20-007493)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477449	Teladoc Health Inc.	TDOC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1375088	C Adam Vandervoort	C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577	Chief Legal Officer, Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-06-15	1,136	$0.00	1,336	No	4	M	Direct
Common Stock	Disposition	2020-06-15	547	$175.57	789	No	4	S	Direct
Common Stock	Disposition	2020-06-16	589	$184.81	200	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2020-06-15	1,136	$0.00	1,136	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,136			No	4	M	Direct

Footnotes

Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
Restricted stock units convert to common stock on a one-for-one basis.
On June 14, 2017, the reporting person was was granted 4,545 restricted stock units, vesting in four equal annual installments beginning on June 14, 2018.
Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020.